{"transactions":[{"id":3604432,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":159312,"kind":"person","name":"Mancilla Bethany","position":1,"cik":"0001748840","reported_name":"Mancilla Bethany","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-08T16:13:39.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a stock option award granted on August 1, 2018 that partially vested upon the achievement of certain performance based conditions as determined by the Compensation Committee of Cue Biopharma, Inc. on March 6, 2019. As of March 6, 2019, 50,000 of these options were vested and exercisable. The remaining 50,000 will become vested and exercisable only upon the achievement of certain performance based conditions."}],"balance_after":100000,"derivative":{"exercise_price":9.54,"expiration_date":"2025-08-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-018088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1748840/000120919119018088/doc4.xml","form_type":"4"}},{"id":3604431,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":159312,"kind":"person","name":"Mancilla Bethany","position":1,"cik":"0001748840","reported_name":"Mancilla Bethany","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-08T16:13:39.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019."}],"balance_after":65000,"derivative":{"exercise_price":6.42,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-19-018088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1748840/000120919119018088/doc4.xml","form_type":"4"}},{"id":3855148,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":159312,"kind":"person","name":"Mancilla Bethany","position":1,"cik":"0001748840","reported_name":"Mancilla Bethany","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-02T17:14:17.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning February 1, 2019."}],"balance_after":250000,"derivative":{"exercise_price":9.54,"expiration_date":"2025-08-01","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-18-045024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1748840/000120919118045024/doc4.xml","form_type":"4"}}]}